SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001615219-22-000022
Filing Date
2022-03-10
Accepted
2022-03-10 16:12:52
Documents
14
Period of Report
2022-03-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K flks-20220310.htm   iXBRL 8-K 36644
2 EX-99.1 salarius4q-fyearningspr022.htm EX-99.1 87441
6 image_0a.jpg GRAPHIC 111465
  Complete submission text file 0001615219-22-000022.txt   419252

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT flks-20220310.xsd EX-101.SCH 1924
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT flks-20220310_lab.xml EX-101.LAB 23892
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT flks-20220310_pre.xml EX-101.PRE 12541
8 EXTRACTED XBRL INSTANCE DOCUMENT flks-20220310_htm.xml XML 11337
Mailing Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021 346-772-0346
Salarius Pharmaceuticals, Inc. (Filer) CIK: 0001615219 (see all company filings)

IRS No.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36812 | Film No.: 22729182
SIC: 2834 Pharmaceutical Preparations